SCHEMBL8906379

SCHEMBL8906379

[O]CCCCOCc1ccsc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 2/20 0.40
SLC1A2 P43004 2/20 0.40
SLC1A1 P43005 2/20 0.40
TAAR1 Q96RJ0 1/20 0.37
PARP15 Q460N3 1/20 0.37
PARP10 Q53GL7 1/20 0.37
PARP3 Q9Y6F1 1/20 0.37
HPGD P15428 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
MEN1 O00255 1/20 0.33
KDM4A O75164 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
SLC6A2 P23975 1/20 0.32
SLC6A3 Q01959 1/20 0.32
DRD2 P14416 1/20 0.32
DRD3 P35462 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8905224 0.95 SLC1A3 (0.44) SLC1A3SLC1A2SLC1A1TAAR1PARP15
SCHEMBL2340489 0.82 DRD2 (0.42) SLC1A3SLC1A2SLC1A1TAAR1PARP15
SCHEMBL15412571 0.81 DRD2 (0.41) SLC1A3SLC1A2SLC1A1TAAR1L3MBTL1
SCHEMBL13610226 0.81 DRD2 (0.41) SLC1A3SLC1A2SLC1A1TAAR1L3MBTL1
SCHEMBL15412981 0.81 DRD2 (0.41) SLC1A3SLC1A2SLC1A1TAAR1L3MBTL1
SCHEMBL8945514 0.81 TAAR1 (0.36) SLC1A3SLC1A2SLC1A1TAAR1PARP15
SCHEMBL20912423 0.80 SLC1A3 (0.46) SLC1A3SLC1A2SLC1A1HPGDALDH1A1
SCHEMBL6042877 0.80 SLC1A3 (0.41) SLC1A3SLC1A2SLC1A1TAAR1PARP15
SCHEMBL3356356 0.80 DRD2 (0.43) SLC1A3SLC1A2SLC1A1TAAR1PARP15
SCHEMBL8904834 0.79 TAAR1 (0.46) SLC1A3SLC1A2SLC1A1TAAR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5659065-A CHEMICAL INTERMEDIATES FOR MEDICINAL ACTIVE AGENTS NOVARTIS CORPORATION (US) 1997-08-19 US disclosed
EP-0678500-A1 Alpha-amino alkanoic acids and reduction products as intermediates in the preparation of renin inhibitors CIBA-GEIGY AG (CH) 1995-10-25 EP disclosed